Scholarlink

Background <p>Frozen shoulder (FS) is a painful, stiff and disabling shoulder condition affecting adults of working age. A multi-centre randomised controlled trial (UK FROST) comparing three of the most common treatments provided by the National Health Service (NHS) in secondary care found all three treatments improved patient outcomes, with none being overall clinically superior. Each treatment had its advantages and disadvantages. This paper describes the use of the Consolidated Framework of Implementation Research (CFIR) as an exemplar of knowledge translation for the latest evidence from UK FROST in the management of FS. It describes using stakeholder feedback in the development of a FS pathway, considering the barriers and facilitators to implementation in relation to the UK FROST findings and current clinical practice.</p> Methods <p>Healthcare professionals, academics, policymakers and patient and public representatives were invited as stakeholders to three meetings held in November 2022 and January 2023. An overview of the United Kingdom Frozen Shoulder Trial (UK FROST) study, current pathways, referral processes and guidelines for FS in the context of the study results and the development of patient resources were discussed at the first meeting in November. Outcomes from this meeting informed the January meetings. The CFIR was used to guide analysis of the discussions from the stakeholder meetings.</p> Results <p>Overall, 67 stakeholders attended across three meetings. From the meetings, we categorised the FS pathway into four components (1) presentation and assessment; (2) initial management; (3) treatment options – physiotherapy and steroid injection, secondary care referrals; and (4) enhanced recovery and follow-up, with shared decision-making emphasised throughout the pathway. Barriers and facilitators in each of the pathway components were identified using the five domains of the CFIR. A proposed evidence-based FS pathway was developed with stakeholders using an eight-step process.</p> Conclusions <p>This study has led to the development of an evidence-based FS care pathway, ready to be considered by policymakers for implementation, with considerations of barriers and facilitators. There was consensus that it is feasible to embed a modified physiotherapy intervention form UK FROST within current primary and community care settings to optimise service delivery and referral pathways.</p> <p><i>Trial Registration</i> The trial registration is ISRCTN48804508.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Implementing evidence into practice for the management of frozen shoulder: engaging with key stakeholders and evaluating barriers and facilitators using the Consolidated Framework for Implementation Research

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月30日

查看全文
  • Natalie Louise Clark,
  • Melissa Johnson,
  • Lucksy Kottam,
  • Stephen Brealey,
  • Joy Adamson,
  • Amar Rangan,
  • Simon Aldous,
  • Alison Armstrong,
  • Annabelle Armitage,
  • Cheryl Baldwick,
  • Jenna Bardsley,
  • Andrew Bennett,
  • Brian Blacklidge,
  • Rowena Broughton,
  • Fran Cabry,
  • Aimee Carr,
  • Charalambos P. Charalambous,
  • Caroline Christmas,
  • Peter E. J. Clark,
  • Eleanor S. Cramb,
  • Linda Furness,
  • Ann-Marie Ginnever,
  • Kate Graham,
  • Paul William Green,
  • Jillian Hughes,
  • Maya Jafari,
  • Anju Jaggi,
  • Falama Kadafa,
  • Cormac Kelly,
  • Su Leeming,
  • Jeehan Lynch,
  • Clare Mitchell,
  • Sibongile Mtopo,
  • Lynn Nelson,
  • Simon Nicole,
  • Jayanti Rai,
  • Adnan Saithna,
  • Gemma Shearer,
  • Claire Southey,
  • Kate Stevenson,
  • Helen Thompson,
  • Suzanne Timney,
  • David Tomson,
  • Aisha Warsama,
  • Helen Watson,
  • Mark Robert Webb,
  • Gareth Whelan,
  • Chris Wright

摘要

Background

Frozen shoulder (FS) is a painful, stiff and disabling shoulder condition affecting adults of working age. A multi-centre randomised controlled trial (UK FROST) comparing three of the most common treatments provided by the National Health Service (NHS) in secondary care found all three treatments improved patient outcomes, with none being overall clinically superior. Each treatment had its advantages and disadvantages. This paper describes the use of the Consolidated Framework of Implementation Research (CFIR) as an exemplar of knowledge translation for the latest evidence from UK FROST in the management of FS. It describes using stakeholder feedback in the development of a FS pathway, considering the barriers and facilitators to implementation in relation to the UK FROST findings and current clinical practice.

Methods

Healthcare professionals, academics, policymakers and patient and public representatives were invited as stakeholders to three meetings held in November 2022 and January 2023. An overview of the United Kingdom Frozen Shoulder Trial (UK FROST) study, current pathways, referral processes and guidelines for FS in the context of the study results and the development of patient resources were discussed at the first meeting in November. Outcomes from this meeting informed the January meetings. The CFIR was used to guide analysis of the discussions from the stakeholder meetings.

Results

Overall, 67 stakeholders attended across three meetings. From the meetings, we categorised the FS pathway into four components (1) presentation and assessment; (2) initial management; (3) treatment options – physiotherapy and steroid injection, secondary care referrals; and (4) enhanced recovery and follow-up, with shared decision-making emphasised throughout the pathway. Barriers and facilitators in each of the pathway components were identified using the five domains of the CFIR. A proposed evidence-based FS pathway was developed with stakeholders using an eight-step process.

Conclusions

This study has led to the development of an evidence-based FS care pathway, ready to be considered by policymakers for implementation, with considerations of barriers and facilitators. There was consensus that it is feasible to embed a modified physiotherapy intervention form UK FROST within current primary and community care settings to optimise service delivery and referral pathways.

Trial Registration The trial registration is ISRCTN48804508.